OVARIAN CANCER

Ovarian cancer is common gynecologic cancer, female genital tumors about 1 / 3. Can occur at any age, and women with reproductive seen. The incidence of ovarian cancer is women's genital cancer Habitat third place, as early diagnosis difficult, often found at the already advanced, but the mortality rate for the first gynecologic malignancies.
[Diagnosis]

A Symptoms

(1) abdominal discomfort or medium sized benign tumor rapid growth often cause bloating and discomfort.

(2) abdominal mass benign swelling growth slow, difficult to be discovered, patients are often inadvertently touched. Malignant tumors grow fast, easily detected.

Tags: abdominal, age, anti, benign, bleeding, blood, cancer, carcinoma, cause, cell, cells, cyst, cystic, diagnosis, early, eat, ert, estrogen, examination, gene, growth, incidence, increased, lymph, malignant, mass, metastasis, metastatic, node, oppression, ovarian, ovary, pain, patients, pelvic, positive, rate, reduce, surface, symptoms, tumor, tumors, uterine, women

Ovarian cancer mortality first Habitat gynecologic malignancies, as misprision of onset, 70% of patients when treatment is already advanced. Surgery and chemotherapy comprehensive application is the treatment of advanced ovarian cancer, especially epithelial ovarian cancer therapy of choice. Platinum drug resistance ovarian cancer is the main reason for treatment failure. To solve this problem, clinical oncologist to a variety of solutions, is chosen in 2003 after the open literature on the following:

Tags: anti, cancer, carboplatin, cases, cell, cells, chemotherapy, cisplatin, clinical, csa, days, dose, drug, drugs, eat, head, injection, intravenous, method, ovarian, paclitaxel, patients, positive, rate, reduce, response, study, surgery, survival, therapy, time, toxicity, treatment

[Summary]

Ovarian cancer is a common cancer of female genital mutilation one of the incidence of cervical cancer and after cancer of the uterus, which ranked third. But ovarian cancer death, accounts of the first gynecologic tumors, right pose a serious threat to women's lives. Because ovarian embryonic development, organization anatomy and endocrine function more complicated, it may be suffering from benign tumors or malignant. Because of early ovarian cancer in asymptomatic, and the identification of its type benign and malignant very difficult, ovarian carcinoma laparotomy in ovarian tumor confined to only 30%, most have spread to the uterus, bilateral annex, the omentum and pelvic organs, both in the diagnosis of ovarian cancer and governance the treatment is a major problem indeed. Over the years experts on the pathological form of ovarian cancer, the development of clinical and treatment programs for many of accumulated a lot of experience, so far, statistics on domestic and foreign clinical data, the five-year survival rate of only 25% to 30%.

Tags: abdominal, age, amenorrhea, annex, anti, benign, bleeding, blood, body, cancer, carcinoma, care, cases, cause, cell, cells, chemotherapy, clinical, cyst, cystic, days, diagnosis, dose, drug, drugs, early, eat, ert, estrogen, examination, exploration, gene, grams, growth, gynecological, history, incidence, increased, injection, intraperitoneal, intravenous, irradiation, life, lymph, malignant, mass, metastasis, method, node, oppression, ovarian, ovary, pain, patients, pelvic, poor, prognosis, protein, radiation, radiotherapy, rate, reduce, resection, residual, screening, staging, surface, surgery, surgical, survival, symptoms, syndrome, therapy, time, toxicity, treatment, tumor, tumors, uterine, women

Ovarian cancer
	Ovarian cancer is a malignancy in ovarian tissue. Clinically, there will be abdominal discomfort, abdominal pain, abdominal mass, menstrual disorders, oppression and other symptoms. Ovarian cancer onset conceal, not found early, easy transfer characteristics of poor prognosis. Of all gynecologic malignancies around 15%. The incidence of ovarian cancer in common malignancy in women as a percentage of 2.4-5.6%. In the female reproductive tract malignancies in the third place, behind cervical and uterine corpus cancer. In women's reproductive tract cancers, ovarian cancer is the highest cause of death of a tumor. Ovarian cancer can occur at any age. Ovarian cancer belong to the medicine "of Zheng Jia", "build up" areas.

Tags: abdominal, age, body, cancer, cause, cell, cells, clinical, early, eat, incidence, mass, oppression, ovarian, pain, poor, prognosis, symptoms, tumor, uterine, women

(1) B - ultrasound imaging can detect tumor location, size, shape and nature.

(2) radiology diagnostic barium contrast barium enema or air contrast to know whether gastrointestinal tumors. CT of pelvic tumors can locate and identify and understand the liver, lung and retroperitoneal lymph node metastasis there. Contrast pelvic lymph nodes can be judged without milk ovarian tumor lymphatic metastasis.

(3) laparoscopy can be directly observed tumor sources and generally, and the entire basin and transverse abdominal separated, and to determine the scope of other diseases. Ascites and lessons for cytology, or from dubious organizations for pathological examination. However, the enormous mass or tumor adhesion taboo.

Tags: abdominal, age, anti, cancer, carcinoma, cell, cells, cyst, cystic, diagnosis, early, eat, ert, examination, gene, increased, lymph, mass, metastasis, node, ovarian, ovary, patients, pelvic, positive, rate, reduce, tumor, tumors, women

Ovarian cancer is the female reproductive system cancer one of the three, as misprision of clinical symptoms, the lack of an effective method for early diagnosis, over 80% of patients had treatment for late mortality gynecologic malignancies in the first place. CA-125 tumor marker specificity is not strong, there false positive, we can not separate screening for ovarian cancer. High-throughput protein groups for the study of information technology and biological tools for ovarian cancer biomarkers of mass rapid screening provided a powerful weapon.

Tags: age, anti, benign, blood, body, cancer, cases, cell, cells, clinical, diagnosis, early, eat, eggs, gene, group, groups, increased, malignant, mass, method, ovarian, patients, positive, prostasin, protein, rate, screening, study, surgery, symptoms, treatment, tumor, tumors

Currently, the incidence rates of ovarian cancer accounts for gynecologic malignancy in 23% ~ 27% as the world's five largest high cancer mortality leapt gynecologic tumors in the first place. It can happen to women of any age, but occurred in the before and after menopause, about half occurred after the age of 65.

Tags: administration, age, body, cancer, cause, cell, cells, chemotherapy, clinical, diagnosis, drug, early, eat, ert, examination, gene, gynecological, incidence, intraperitoneal, life, metastasis, method, ovarian, patients, pelvic, quality, radiotherapy, rate, resection, residual, surgery, surgical, survival, symptoms, therapy, time, treatment, tumor, tumors, women

Ovarian cancer

Tags: body, cancer, carcinoma, cell, cells, cyst, cystic, incidence, malignant, ovarian, patients, rate, second, surface, tumor, tumors

In early ovarian cancer, most patients will not notice, because some of its symptoms and other gynecological diseases with similar symptoms, so women should carefully observe the physical changes, they can not tell if it is normal or abnormal, as soon as possible to help to gynecologists must not be negligent.
One month after little or amenorrhea

The majority of patients with ovarian cancer menstrual changes. If ovarian cancer cells were normal tissue damage in patients with systemic poor state, there will be a few months or amenorrhea.
2, abdominal distension

Tags: abdominal, age, amenorrhea, bleeding, cancer, care, cause, cell, cells, early, ert, estrogen, examination, fat, gynecological, lymph, mass, oppression, ovarian, pain, patients, pelvic, physical, poor, reduce, symptoms, time, tumor, tumors, women

" Cancer, "a magazine published care Ovarian cancer.

A total of 80,326 women aged 30-55 who participated in the study began in 1976. Subjects in 1980,1984,1986 and 1990 to complete the consumption frequency of the survey questionnaire. In more than 16 years of follow-up period in subjects with 527 cases of ovarian cancer.

Boston, Harvard University Kathleen M. Fairfield School of Medicine and colleagues, multivariate analysis showed that: intake of vitamin A, vitamin C or beta-carotene and the risk of ovarian cancer unrelated.

Tags: age, anti, cancer, care, cases, cause, cell, cells, dose, early, ovarian, reduce, risk, study, time, women